Zoetis Inc. $ZTS Shares Newly Acquired by Marathon Wealth Advisors LLC

Marathon Wealth Advisors LLC bought a new position in Zoetis Inc. (NYSE:ZTS) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 12,057 shares of the company’s stock, valued at approximately $842,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. increased its position in shares of Zoetis by 10.8% in the second quarter. BlackRock Inc. now owns 39,430,181 shares of the company’s stock worth $2,833,453,000 after acquiring an additional 3,845,869 shares in the last quarter. State Street Corp raised its holdings in shares of Zoetis by 1.8% during the second quarter. State Street Corp now owns 19,667,723 shares of the company’s stock valued at $1,413,323,000 after acquiring an additional 343,322 shares during the period. Bank of America Corp DE lifted its position in shares of Zoetis by 7.3% in the 1st quarter. Bank of America Corp DE now owns 4,831,652 shares of the company’s stock valued at $571,150,000 after acquiring an additional 327,313 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Zoetis by 5.8% in the 2nd quarter. Deutsche Bank AG now owns 5,851,737 shares of the company’s stock valued at $420,506,000 after acquiring an additional 319,709 shares in the last quarter. Finally, Van ECK Associates Corp lifted its position in shares of Zoetis by 7.7% in the 2nd quarter. Van ECK Associates Corp now owns 4,252,140 shares of the company’s stock valued at $305,559,000 after acquiring an additional 303,395 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ZTS has been the subject of a number of recent analyst reports. Jefferies Financial Group raised their price objective on shares of Zoetis from $83.00 to $85.00 in a research note on Friday, November 6th. TD Cowen cut their target price on shares of Zoetis from $104.00 to $94.00 and set a “buy” rating on the stock in a research note on Tuesday, August 25th. Stifel Nicolaus cut their target price on shares of Zoetis from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, August 20th. JPMorgan Chase & Co. reduced their target price on Zoetis from $130.00 to $115.00 and set an “overweight” rating for the company in a report on Friday, August 7th. Finally, UBS Group raised their target price on Zoetis from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 27th. Eight research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $101.25.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $82.48 on Wednesday. The firm has a market cap of $33.51 billion, a price-to-earnings ratio of 14.03, a P/E/G ratio of 1.19 and a beta of 0.67. Zoetis Inc. has a 1 year low of $68.77 and a 1 year high of $132.49. The company has a current ratio of 2.35, a quick ratio of 1.40 and a debt-to-equity ratio of 2.51. The business has a fifty day simple moving average of $75.88 and a 200 day simple moving average of $92.18.

Zoetis (NYSE:ZTS) last issued its earnings results on Thursday, November 5th. The company reported $1.75 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.24. Zoetis had a return on equity of 85.90% and a net margin of 26.15%. The firm had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.30 billion. During the same quarter in the previous year, the company posted $1.70 earnings per share. The business’s quarterly revenue was down 1.3% compared to the same quarter last year. As a group, sell-side analysts predict that Zoetis Inc. will post 6.29 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, October 30th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 30th. Zoetis’s payout ratio is currently 36.05%.

About Zoetis

Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.